Related Experiment Video
Updated: May 1, 2026

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
Effect of Functionally Selective Dopamine D1 Receptor Agonists on Complex Cognitive Processes in a Rodent Touchscreen
Ava P Bassett1, Luke Bransom1, Richard B Mailman2
1Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, Pennsylvania 17033.
Abstract:
Dopamine D1 receptor (D1R) signaling in the brain has been strongly implicated in multiple cognitive processes, with D1 agonists known to enhance performance. The development of functionally selective D1 agonists that differentially activate D1R-mediated cAMP versus β-arrestin signaling may offer precision therapy if we understand how signaling bias impacts integrated cognitive processes in complex tasks. We therefore examined the effects of two selective D1 agonists, 2-methyldihydrexidine (2MDHX) and PF-06256142 (PF), on a rodent touchscreen-based Trial-Unique Nonmatching-To-Location task. Primarily assessing both spatial working memory and pattern separation in adult male rats, this behavioral paradigm requires greater cognitive demands to maintain performance throughout the testing session, significantly increasing task complexity. Our results revealed an inverted U-shaped dose response curve for both compounds, aligning with our previously published work, but did not demonstrate marked improvement in task performance. Subjects treated with the mid-dose range (10, 100, and 1,000 nmol/kg) generally performed similarly to, or slightly below, vehicle treated subjects whereas the highest dose administered (10,000 nmol/kg) significantly reduced task performance and engagement. The behavioral effects were similar for PF and 2MDHX, suggesting that functional selectivity/bias (at least for the cAMP versus β-arrestin signaling pathways) was not a major factor in this cognitive task. In addition to providing new information about how D1 agonists might affect different aspects of cognition, our data underscores the importance of dose optimization and task structure and showcases the translational value of touchscreen-based paradigms when assessing potential cognitive enhancers.

